Update upon the infection risk in patients receiving TNF alpha inhibitors
Sign Up to like & getrecommendations! Published in 2019 at "Expert Opinion on Drug Safety"
DOI: 10.1080/14740338.2019.1577817
Abstract: ABSTRACT Introduction: TNF-α inhibitors can be administered either as monotherapy or in combination with other anti-inflammatory drugs or DMARDs in the treatment of chronic immune-mediated diseases. Areas covered: Patients receiving TNF-α inhibitors are at high… read more here.
Keywords: risk; update upon; infection; patients receiving ... See more keywords